Postoperative Total Wavefront Pattern Between Two Types of Intraocular Lenses Implanted in Cataract Surgery
Difference in Postoperative Total Wavefront Pattern Between Aspheric and Negative Spherical Aberration Intraocular Lenses Implanted in Cataract Surgery
1 other identifier
interventional
40
1 country
1
Brief Summary
With the advancement of cataract eye surgery and wavefront sensors, the previously unquantifiable refractive measurements have been identified and the high order aberrations have shown their effect on high resolution imaging. In the human phakic eye, the shape of the normal cornea induces average positive spherical aberration and remains unchanged over time, whereas the crystalline lens has a negative spherical aberration. As a result, overall spherical aberration in the young eye is low. However, the compensation slowly decreases with the aging lens and is fully lost after cataract extraction and implantation of a standard intraocular lens. Optical studies showed that conventional biconvex spherical intraocular lenses add their intrinsic positive spherical aberration to the positive spherical aberration of the cornea resulting in image imperfection and blur. As a useful side effect, this also increases the depth of focus -often referred to as pseudo-accommodation. New Aspheric intraocular lenses designs currently in use impart negative spherical aberration, about 0.17 to 0.20 microns of negative spherical aberration. This added negative spherical aberration partially corrects the average amount of corneal positive spherical aberration \& compensate for its effect. Our study will include (FocusForce foldable aspheric intraocular lens, Bausch \& Lomb, New Jersey, USA) as an example of this type of negative spherical aberration intraocular lenses. In order to improve retinal image quality without compromising depth of field, or introducing other aberrations, aberration-free aspheric intraocular lenses were developed with no inherent spherical aberration. The other intraocular lens targeted in our study (Akreos AO Microincision lens, Bausch \& Lomb, New Jersey, USA) is an example of this type of IOLs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2020
CompletedFirst Submitted
Initial submission to the registry
January 6, 2021
CompletedFirst Posted
Study publicly available on registry
January 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJanuary 13, 2021
January 1, 2021
8 months
January 6, 2021
January 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Corneal, Ocular, and Internal spherical aberrations
assessment of ocular, corneal \& internal wavefront by aberrometer \& corneal tomography
1 month postoperative
Secondary Outcomes (2)
corneal wavefront changes
1 month postoperative
near vision addition
1 month postoperative
Study Arms (2)
aberration-free IOL
EXPERIMENTAL20 human eyes with aberration-free intraocular lens Implantation after phacoemulsification cataract surgery
negative spherical aberration IOL
ACTIVE COMPARATOR20 human eyes with negative spherical aberration intraocular lens Implantation after phacoemulsification cataract surgery
Interventions
treatment of cataract by phacoemulsification procedure and implantation of different types of IOLs.
evaluate total ocular wavefront, corneal wavefront \& internal wavefront (High order aberrations ) post operative by corneal tomography and aberrometer
Eligibility Criteria
You may qualify if:
- All patients with written informed consent, between the age of 21 -75 years who will undergo phacoemulsification procedure with intraocular lens implantation of one of the targeted lenses in the study
You may not qualify if:
- Previous corneal intervention or refractive surgery.
- Persistent Corneal edema (epithelial or stromal).
- Co-existing corneal pathology.
- Ocular surface disease \& Dry eye syndrome.
- Posterior capsular opacity .
- Anterior capsular contraction (phimosis).
- Ocular inflammation.
- Co-existing Vitreoretinal diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
facultyof medicine, Cairo university
Cairo, 12563, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aya G Ibrahim, MBBCh
Dar El Oyoun ophthalmology hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident of ophthalmology
Study Record Dates
First Submitted
January 6, 2021
First Posted
January 8, 2021
Study Start
November 9, 2020
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
January 13, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share